Qinghai Spring Medicinal Resources Technology Co., Ltd. (600381.SS)
CNY 3.46
(-3.07%)
CNY 3.46
(-3.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 213.87 Million | 160.17 Million | 127.76 Million | 124.26 Million | 233.74 Million | 333.01 Million |
| Cost of Revenue | 84.6 Million | 86.31 Million | 102.55 Million | 100.53 Million | 168.74 Million | 234.29 Million |
| Gross Profit | 129.27 Million | 73.86 Million | 25.21 Million | 23.73 Million | 64.99 Million | 98.71 Million |
| Operating Expenses | 390 Million | 201.68 Million | 126.44 Million | 126.46 Million | 110.58 Million | 145.66 Million |
| Selling, General and Administrative Expenses | 191.8 Million | 137.49 Million | 67.72 Million | 66.07 Million | 63.31 Million | 105.99 Million |
| Research and Development Expenses | 11.63 Million | 11.37 Million | 9.53 Million | 12.29 Million | 4.49 Million | 3.03 Million |
| Other Expenses | 186.45 Million | 52.81 Million | 49.18 Million | 48.08 Million | 42.77 Million | 42.7 Million |
| Cost and Expenses | 474.6 Million | 288 Million | 228.99 Million | 226.99 Million | 279.33 Million | 379.96 Million |
| Operating Income | -258.98 Million | -127.82 Million | -101.22 Million | -20.28 Million | 7.93 Million | 20.93 Million |
| Interest Expense | 962.43 Thousand | 91.59 Thousand | 52.13 Thousand | 155.77 Thousand | 154.83 Thousand | 11.11 Thousand |
| Income Tax Expense | 5.93 Million | -7.71 Million | -3.84 Million | 4.5 Million | -7.52 Million | -5 Million |
| Earnings before Tax | -260.28 Million | -295.26 Million | -252.45 Million | -315.03 Million | -1.72 Million | 63.64 Million |
| Net Income | -267.86 Million | -287.55 Million | -248.61 Million | -319.54 Million | 5.8 Million | 68.44 Million |
| Earnings Per Share Basic | -0.46 | -0.49 | -0.42 | -0.54 | 0.01 | 0.12 |
| Earnings Per Share Diluted | -0.46 | -0.49 | -0.42 | -0.54 | 0.01 | 0.12 |
| Weighted Average Shares Outstanding | 582.31 Million | 587.06 Million | 587.06 Million | 587.06 Million | 587.06 Million | 570.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 582.31 Million | 587.06 Million | 587.06 Million | 587.06 Million | 587.06 Million | 570.39 Million |
| Gross Margin | 0.60 | 0.46 | 0.20 | 0.19 | 0.28 | 0.30 |
| EBIT Margin | -0.91 | -0.83 | -0.85 | 0.17 | 0.21 | 0.34 |
| Profit Margin | -1.25 | -1.80 | -1.95 | -2.57 | 0.02 | 0.21 |
| EBITDA | -195.2 Million | -232.16 Million | -178.9 Million | 21.23 Million | 20.68 Million | 111.96 Million |
| Earnings Before Tax Margin | -1.21 | -0.80 | -0.79 | -0.16 | 0.03 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 59.65 Million | 52.81 Million | 84.49 Million | 53.16 Million | 213.87 Million | 53.28 Million |
| Cost of Revenue | 39.81 Million | 45.26 Million | 38.64 Million | 28.57 Million | 82.95 Million | 16.49 Million |
| Gross Profit | 19.83 Million | 7.55 Million | 45.85 Million | 24.58 Million | 130.91 Million | 36.79 Million |
| Operating Expenses | 49.07 Million | 38.47 Million | 69.69 Million | 64.54 Million | 236.79 Million | 52.99 Million |
| Selling, General and Administrative Expenses | 67.7 Million | 32.91 Million | 67.66 Million | 29.36 Million | - | 63.81 Million |
| Research and Development Expenses | 3.39 Million | 5.55 Million | 1.19 Million | 4.08 Million | - | 4.3 Million |
| Other Expenses | -22.02 Million | -2.04 Million | 704.45 | 48.74 Thousand | -1.29 Million | -1.21 Million |
| Cost and Expenses | 88.88 Million | 83.73 Million | 108.34 Million | 93.12 Million | 319.75 Million | 69.48 Million |
| Operating Income | -29.01 Million | -30.91 Million | -23.78 Million | -195.86 Million | -258.98 Million | -16.05 Million |
| Interest Expense | 1705.06 | 357.86 Thousand | 212.84 Thousand | 264.8 Thousand | 913.17 Thousand | 188.89 Thousand |
| Income Tax Expense | 358.15 Thousand | 1.16 Million | 2.17 Million | 1.82 Million | 5.93 Million | 2.22 Million |
| Earnings before Tax | -30.31 Million | -30.84 Million | -23.78 Million | -195.81 Million | -260.28 Million | -17.27 Million |
| Net Income | -30.58 Million | -32.96 Million | -26.9 Million | -197.53 Million | -267.86 Million | -19.74 Million |
| Earnings Per Share Basic | -0.05 | -0.06 | -0.05 | -0.34 | - | -0.03 |
| Earnings Per Share Diluted | -0.05 | -0.06 | -0.05 | -0.34 | - | -0.03 |
| Weighted Average Shares Outstanding | 577.01 Million | 586.87 Million | 587.44 Million | 576.37 Million | 582.31 Million | 587.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 577.01 Million | 586.87 Million | 587.44 Million | 576.37 Million | 582.31 Million | 587.06 Million |
| Gross Margin | 0.33 | 0.14 | 0.54 | 0.46 | 0.61 | 0.69 |
| EBIT Margin | -0.51 | -0.43 | -0.28 | -2.94 | - | -0.32 |
| Profit Margin | -0.51 | -0.62 | -0.32 | -3.72 | -1.25 | -0.37 |
| EBITDA | -30.31 Million | -22.85 Million | -23.6 Million | -156.24 Million | - | -17.08 Million |
| Earnings Before Tax Margin | -0.49 | -0.59 | -0.28 | -3.68 | -1.21 | -0.30 |
688083
AXNVF
ERVFF
GODREJPROP
VGGIF
AVLP